Canada Life’s Artivion AORT Stock Holding History

Canada Life’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.28M	Hold	34,993	–	–	﹤0.01%	1294
2025 Q4	$1.6M	Buy	34,993 +1,828	+6%	+$81.4K	﹤0.01%	1236
2025 Q3	$1.39M	Hold	33,165	–	–	﹤0.01%	1348
2025 Q2	$1.03M	Buy	33,165 +2,253	+7%	+$61K	﹤0.01%	1423
2025 Q1	$761K	Sell	30,912 -5,978	-16%	-$166K	﹤0.01%	1504
2024 Q4	$1.05M	Sell	36,890 -14,756	-29%	-$409K	﹤0.01%	1457
2024 Q3	$1.37M	Buy	51,646 +700	+1%	+$18.2K	﹤0.01%	1433
2024 Q2	$1.31M	Buy	50,946 +16,485	+48%	+$370K	﹤0.01%	1439
2024 Q1	$729K	Buy	34,461 +2,531	+8%	+$47.1K	﹤0.01%	1585
2023 Q4	$570K	Buy	31,930 +2,100	+7%	+$32.7K	﹤0.01%	1676
2023 Q3	$452K	Sell	29,830 -3,044	-9%	-$49.3K	﹤0.01%	1702
2023 Q2	$564K	Sell	32,874 -4,116	-11%	-$60.6K	﹤0.01%	1658
2023 Q1	$483K	Sell	36,990 -4,241	-10%	-$54.2K	﹤0.01%	1711
2022 Q4	$500K	Sell	41,231 -3,533	-8%	-$42.4K	﹤0.01%	1722
2022 Q3	$619K	Buy	44,764 +4,678	+12%	+$94.2K	﹤0.01%	1641
2022 Q2	$756K	Buy	40,086 +5,874	+17%	+$113K	﹤0.01%	1573
2022 Q1	$750K	Hold	34,212	–	–	﹤0.01%	1612
2021 Q4	$696K	Sell	34,212 -223	-0.6%	-$4.5K	﹤0.01%	1638
2021 Q3	$773K	Buy	34,435 +1,611	+5%	+$41.5K	﹤0.01%	1607
2021 Q2	$932K	Hold	32,824	–	–	﹤0.01%	1548
2021 Q1	$741K	Sell	32,824 -5,383	-14%	-$132K	﹤0.01%	1625
2020 Q4	$902K	Sell	38,207 -3,290	-8%	-$66.7K	﹤0.01%	1552
2020 Q3	$766K	Sell	41,497 -4,541	-10%	-$86.8K	﹤0.01%	1520
2020 Q2	$881K	Sell	46,038 -1,955	-4%	-$41.5K	﹤0.01%	1500
2020 Q1	$810K	Buy	47,993 +2,223	+5%	+$57K	﹤0.01%	1399
2019 Q4	$1.23M	Buy	+45,770	New	+$1.12M	﹤0.01%	1389
2019 Q3	–	Sell	-45,605	Closed	-$1.36M	–	1177
2019 Q2	$1.36M	Hold	45,605	–	–	﹤0.01%	1376
2019 Q1	$1.33M	Buy	45,605 +1,877	+4%	+$53.5K	﹤0.01%	1270
2018 Q4	$1.14M	Buy	43,728 +3,049	+7%	+$91.7K	﹤0.01%	1341
2018 Q3	$1.43M	Hold	40,679	–	–	﹤0.01%	1371
2018 Q2	$1.13M	Sell	40,679 -1,169	-3%	-$29.5K	﹤0.01%	1486
2018 Q1	$837K	Sell	41,848 -2,927	-7%	-$56K	﹤0.01%	1569
2017 Q4	$857K	Hold	44,775	–	–	﹤0.01%	1572
2017 Q3	$1M	Buy	44,775 +5,284	+13%	+$107K	﹤0.01%	1516
2017 Q2	$786K	Hold	39,491	–	–	﹤0.01%	1591
2017 Q1	$655K	Buy	39,491 +3,077	+8%	+$54.3K	﹤0.01%	1642
2016 Q4	$698K	Hold	36,414	–	–	﹤0.01%	1607
2016 Q3	$639K	Buy	36,414 +1,926	+6%	+$29.1K	﹤0.01%	1605
2016 Q2	$407K	Buy	+34,488	New	+$407K	﹤0.01%	1701

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Canada Life's AORT Position: Q1 2026 in Review

Canada Life held its Artivion (AORT) position steady in Q1 2026 at 34,993 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Canada Life first reported a position in AORT in Q2 2016 and has held it in 39 quarters since. The position peaked at $1.6M in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

Canada Life held 34,993 shares of Artivion worth $1.28M as of Q1 2026.
Canada Life left its Artivion share count unchanged in Q1 2026.
Artivion made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1294 holding.
Canada Life first reported a position in Artivion in Q2 2016 and has held it in 39 quarters since.
Canada Life's Artivion position peaked at $1.6M in Q4 2025.
239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.